The case against using 5-aminosalicyclates in Crohn's disease: con.

Eduard F Stange

Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany.

Journal Article: Inflammatory Bowel Diseases (impact factor: 4.64). 07/2005; 11(6):613-5.

Source: PubMed

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Science & Research Jobs